Embed Size (px)
DESCRIPTION
MP Advisors started worldwide coverage of the Bio-Pharmaceutical industry in the mid 90s and has witnessed the rise and fall of many large cap and biotech companies. This experience of watching and surviving many Wall Street crisis has taught our analyst team to identify the real value creators vs. those who play to the gallery. Most of our team members have prior experience of working in pharma companies and therefore each one of them brings a first hand knowledge and right contacts with industry executives to make our work different from the street. We work in collaboration with our clients and regularly conduct special projects, including deep-dive assessments of specific opportunities. We are independent thinkers — not broker/dealers.
Citation preview
2
2010 – M P Advisors acted as sole advisor to Intas Biopharmaceuticals Pvt Ltd, a fully
integrated follow-on-biologics company, to raise private equity funding from TATA Capital
2009 – Sell side banker to Banglore Genei, a Biologic company of Sanmar group, Merck KgA
acquired.
2009 – Parabolic Drugs Ltd shares to BTS Advisors/ Swiss Tech PE
2008 – MP conceptualized innovator-generic hybrid model and was strategic advisor Daiichi-
Sankyo on Ranbaxy’s acquisition.
2008 – Sold Tonira Pharma, only API company in India who earns half its revenue from Japan,
to IPCA.
Selected List of Deals by MP Advisors
3
2008 - Acquired an API company in Austria (Loba Chemie) for an Andhra Pradesh
based listed company (Shilpa Medicare)
2008 - Raised INR 200m for Marck Bioscience, a company specializing in Sterile
products from a PE
2007 – Drug Royalty - Assessed market potential of ~a dozen products up to 2015 on behalf of an investor who looks at the royalty income stream
2006 – Conducted due-diligence on behalf of USV, an Indian company wanting to
acquire a Bio-Similar company in Ireland (Genmedix later acquired by Reliance Life
Sciences).
2006 - Advised an EU company BioMerieux in deciding the ranking of different SBU’s of an Indian company, Shantha Biotech, it acquired
Selected List of Deals by MP Advisors
4
2006 - A US based NCE company (Cempra Pharmaceuticals) to source API for the NCE from an
Indian company (Alembic).
2005 - Advised an Indian conglomerate (Atul Ltd) to speed up its pharma division growth.
2004 - Advised one of the top 10 MNC w r t global entry of Vaccine and Insulin business.
2004 -Generated binding bid for an Indian OTC company (Paras Pharma) from an EU company.
2004 - Divested brands of a leading EU company, Solvay in India as part of its global strategy to
Indoco Remedies (Karvol) and Alembic Pharmaceuticals (Yutopar).
2002 - Led first investment in a discovery based US biotech company, Onconova (Philadelphia) by an Indian company Cadila.
Selected List of Deals by MP Advisors
5
Selected List of Deals by MP Advisors
2001 – Sold 35% stake in German Remedies Ltd. Held by four German companies i.e. Asta
Medica (Degussa Hull co), Boehringer Ingelheim, Schering AG & Dr. Falke. Aggressive bidding
was undertaken by Pharmacia, Bristol-Myers Squibb & Cadila.
2001 - Represented an EU company AstraZeneca to buy out its Indian partner, Astra-IDL (A
Hinduja Group Company).
2000- Established JV between a German (Altana) & an Indian company (Cadila) to produce an
“on patent” API (pantaprazole) for global need.
1996 - Licensed out the 1st Indian NCE (Glitazone PhI )from Dr. Reddy’s to an EU company,
Novo Nordisk.
1996 – Acquisition of a US NASDAQ listed Chapter-11 company, Caraco Pharmaceuticals by an
Indian company, Sun Pharmaceuticals (current value ~$250m).
6MP Advisors and/or its affiliates may hold a position in any security or financial instrument mentioned herein. The information contained in this communication is solely intended for the addressee. Access by anyone other than the addressee is unauthorized. Disclosure, copying, and distribution of this information are prohibited.
+91-265-2327096
+1.480.263.9400
www.mpadvisor.com
(o)
(e)
(w)
Contact us:
B-203, Alkapuri Arcade,
R C Dutt Road,
Vadodara – 390007
Address:
Click here to contact us
![· PDF fileMP Marker. -'MP Marker: MP Marker: $4 MP M 03 MP arker: 32 MP 57 P MP MP Marker: 52 MP,M tk M arker:.4 payark MP Market] 45' 44, MP 42 MP Markeižøål](https://img.pdfslide.us/doc/110x75/5a8426c67f8b9ac96a8b63a3/marker-mp-marker-mp-marker-4-mp-m-03-mp-arker-32-mp-57-p-mp-mp-marker-52.jpg)
